Bill > HR5423

This bill, the Gestational Diabetes Act of 2018 or GEDI Act, aims to better understand and reduce gestational diabetes, a form of diabetes that develops during pregnancy. The key provisions of the bill include: 1. Directing the Secretary of Health and Human Services, through the Centers for Disease Control and Prevention (CDC), to develop a research project to expand surveillance data and public health research on gestational diabetes, such as improving data collection, tracking women with gestational diabetes after delivery, and examining factors that influence the risk and incidence of gestational diabetes. 2. Authorizing the Secretary to expand and intensify public health research on gestational diabetes, including developing and testing approaches to improve postpartum diabetes testing and prevent type 2 diabetes in women with a history of gestational diabetes. 3. Providing grants to eligible entities, such as non-profit organizations and state/tribal health agencies, to implement evidence-based interventions to reduce the incidence of gestational diabetes, the recurrence of gestational diabetes in subsequent pregnancies, and the development of type 2 diabetes in women with a history of gestational diabetes. 4. Directing the CDC to work with state and tribal diabetes prevention and control programs to encourage postpartum follow-up care for women with a history of gestational diabetes to reduce the incidence of gestational diabetes, its recurrence, and the development of type 2 diabetes.

Business and Industry

https://www.congress.gov/bill/115th-congress/house-bill/5423/all-info